Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01386398
Brief Title: Vorinostat With or Without Bortezomib in Treating Patients With Refractory or Recurrent Stage IIB, Stage III, or Stage IV Cutaneous T-Cell Lymphoma

First Submitted : June 30, 2011
First Submitted that Met QC Criteria : June 30, 2011
First Posted : July 1, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : January 20, 2015
Last Update Posted : January 21, 2015 (Estimate)